InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Receives $3.7million Grant for Cancer Drug Program 5 Apr 2006 10:11AM $0.200 $0.010 fallen by 95%
- Half Yearly Report/Half Year Accounts 14 Mar 2006 10:31AM $0.200 $0.010 fallen by 95%
- Open Briefing. MD on Genmab Licensing Agreement 16 Feb 2006 8:30AM $0.230 $0.010 fallen by 95.65%
- Genmab licenses Angiogenesis targets from Bionomics 14 Feb 2006 8:35AM $0.225 $0.010 fallen by 95.56%
- Commitments Test Entity - Second Quarter Report 30 Jan 2006 8:31AM $0.200 $0.010 fallen by 95%
- Open Briefing: Bionomics MD on Strategy & Outlook 8 Nov 2005 11:59AM $0.150 $0.010 fallen by 93.33%
- Licenses 2 Epilepsy Diagnostics to Lab Corp of America 3 Nov 2005 8:47AM $0.160 $0.010 fallen by 93.75%
- Bionomicss Granted Patent for Anti-Cancer Compounds 1 Nov 2005 10:14AM $0.150 $0.010 fallen by 93.33%
- Commitments Test Entity - First Quarter Report 28 Oct 2005 10:08AM $0.145 $0.010 fallen by 93.10%
- Open Briefing Bionomics MD on Business Update 7 Sep 2005 10:51AM $0.120 $0.010 fallen by 91.67%
- Receives US allowance of Epilepsy Gene patent 2 Sep 2005 10:50AM $0.115 $0.010 fallen by 91.30%
- Preliminary Final Report 19 Aug 2005 12:48PM $0.110 $0.010 fallen by 90.91%
- Commitments Test Entity - Fourth Quarter Report 29 Jul 2005 8:47AM $0.130 $0.010 fallen by 92.31%
- Presents new data on BN069 at BIO2005 Conference 22 Jun 2005 9:29AM $0.120 $0.010 fallen by 91.67%
- Open Briefing. MD on Iliad Acquisition & Capital Raising 26 May 2005 8:56AM $0.140 $0.010 fallen by 92.86%
- Acquisition of Iliad Chemicals 25 May 2005 9:54AM $0.150 $0.010 fallen by 93.33%
- Trading Halt 23 May 2005 9:41AM n/a $0.010 n/a
- Grant of drug discovery target patent 12 May 2005 11:44AM $0.160 $0.010 fallen by 93.75%
- GABA Grant Extension 5 May 2005 12:16PM $0.150 $0.010 fallen by 93.33%
- Breast Cancer START grant extension 15 Dec 2004 12:39PM n/a $0.010 n/a
- Awarded grants for Antibody Research 4 Nov 2004 10:47AM $0.295 $0.010 fallen by 96.61%
- Licenses Epilepsy Test 27 Sep 2004 8:44AM $0.280 $0.010 fallen by 96.43%
- Louisiana State University Agreement 30 Jul 2004 8:29AM $0.215 $0.010 fallen by 95.35%
- Ion Channel Patent Application accepted in New Zealand 5 Jul 2004 8:49AM $0.215 $0.010 fallen by 95.35%
- Reports progress in devt of gene test for epilepsy 21 Jun 2004 8:58AM $0.220 $0.010 fallen by 95.45%

751 - 775 of 801 results

Page 31 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.